Back Login to subscribe 🔔 Set Alert

AZN AstraZeneca PLC

15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
AZN Fundamental Data
Loading...
Similar Companies
Loading...
AZN Options Chain
Put/Call Ratio
-
-
Expected Move
-
-
Max Pain
-
-
ATM Call Break-even
-
-
ATM Put Break-even
-
-
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
AZN Insider Transactions
Loading insider data…
AZN News
Date Headline Sentiment
Trump Says Administration Recognizing Childhood Vaccine Recommendations For Only 11 Core Vaccinations; Hepatitis B, COVID-19, Influenza No Longer Recommended For All Children
86.07%
AstraZeneca shares are trading higher after reports suggesting that the company didn't have any merger discussions with Bristol Myers Squibb.
93.85%
"There Are 'No Discussions' Happening Between AstraZeneca And Bristol Myers Squibb Over Potential Deal, A Senior Source Close To Matter Says; 'Never Was A Deal To Be Done' Between AstraZeneca And Bristol Myers Squibb" - Reuters Exclusive
92.59%
SOPHiA GENETICS Announces Global Collaboration To Develop, Validate, And Deploy Two Companion Diagnostics Supporting Precision Oncology Therapies With AstraZeneca
53.62%
AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus
80.14%
Yen Intervention And Falling Oil Help Stocks, But Selling In Korea Throws A Monkey Wrench
96.5%
Jim Cramer Senses a 'Fake Out' in Rumored AstraZeneca, Bristol Myers Squibb $400 Billion Mega-Merger
88.98%
AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
97.19%
AstraZeneca shares are trading lower following reports suggesting the company is in discussions with Bristol Myers Squibb to merge.
97.06%
EU Approves Daiichi Sankyo And AstraZeneca's Datroway For First-Line Metastatic TNBC, Showing 5.0 Month Overall Survival Improvement Over Chemotherapy In TROPION-Breast02 Trial
95.47%